Orthofix Medical (OFIX) Cash & Equivalents (2009 - 2026)

Orthofix Medical (OFIX) has 18 years of Cash & Equivalents data on file, last reported at $120.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 107.54% year-over-year to $120.3 million; the trailing twelve-month figure through Mar 2026 stood at $120.3 million (up 107.54% YoY), and the FY2025 full-year result was $82.0 million, down 1.46% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $120.3 million, up from $82.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $120.3 million in Q1 2026 and bottomed at $26.4 million in Q2 2024.
• A 5-year average of $55.5 million and a median of $51.7 million in 2022 frame the typical range for Cash & Equivalents.
• Peak annual rise in Cash & Equivalents reached 151.42% in 2024, while the deepest fall reached 46.04% in 2024.
• Tracing OFIX's Cash & Equivalents over 5 years: stood at $50.7 million in 2022, then plunged by 34.7% to $33.1 million in 2023, then jumped by 151.42% to $83.2 million in 2024, then fell by 1.46% to $82.0 million in 2025, then soared by 46.64% to $120.3 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $120.3 million, $82.0 million, and $62.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison